Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe

Human Genetics

Volumn 98, Issue 3, 1996, Pages 271-280

  Glavač, Damjan ^a,b   Neumann, Hartmut P H ^c   Wittke, Claudia ^a   Jaenig, Hendrik ^a   Mašek, Otakar ^d   Streicher, Teodor ^e   Pausch, Friederike ^a   Engelhardt, Dieter ^f   Plate, Karl H ^c   Höfler, Heinz ^a   Chen, Fan ^g   Zbar, Berton ^g   Brauch, Hiltrud ^a,h  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF PATHOLOGY   (Slovenia)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Zlin Hospital   (Czech Republic)

^e Boynice Hospital   (Slovakia)

^f UNIVERSITY OF MUNICH   (Germany)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CLINICAL FEATURE; CONTROLLED STUDY; GENE MUTATION; GERM LINE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PANCREAS TUMOR; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EUROPE; FEMALE; GENES, TUMOR SUPPRESSOR; GENOTYPE; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; PHENOTYPE;

EID: 9344254346     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050206     Document Type: Article

References (21)

1. Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, Graziano S, Sorenson GD, Poiesz BJ, Minna J, Linehan M, Zbar B (1987) Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med 317:1109-1113
2. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Höfler H, Lerman MI, Zbar B, Neumann HPH (1995) von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum Genet 95:551-556
3. Chen F, Kishida T, Masahiro Y, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt I, Tory K, Kuzmin I, StackhouseT, Latif F, Linehan WM, Lerman MI, Zbar B (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlation with phenotype. Hum Mutat 5: 66-75
4. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER (1994) Identification of intragenic mutations in the Von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308
5. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MW, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzati R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet 7:85-89
6. Hultman T, Stahl S, Hornes E, Uhlen M (1989) Direct solid phase sequencing of genomic and plasmid DNA using magnetic-beads as solid support. Nucleic Acids Res 17:4937-4945
7. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M (1994) Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847
8. Knudson A (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
9. Kuzmin I, Duh FM, Latif F, Geil L, Zbar B, Lerman MI (1995) Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 10:2185-2194
10. Lamiell JM, Salazar FG, Hsia E (1989) Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68:1-29
11. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DSR, Dean M, Glavač D, Richards FM, Crossey PA, Ferguson-Smith MA, Paslier D Le, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320
12. Melmon KL, Rosen SW (1964) Lindau's disease: review of the literature and study of a large kindred. Am J Med 36:595-617
13. Neumann HPH (1987) Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau Syndrome. J Vasc Dis 16:220-226
14. Neumann HPH, Wiestler OD (1991) Clustering of features of von Hippel-Lindau disease: evidence of a complex genetic locus. Lancet 337:1052-1054
15. Neumann HPH, Eng C, Mulligan LM, Glavač D, Zäuner I, Ponder BAJ, Crossey PA, Maher ER, Brauch H (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. JAMA 274:1149-1151
16. Ravnik-Glavač M, Glavač D, Dean M (1994) Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet 3:801-807
17. Ritter MM, Frilling A, Crossey PA, Höppner W, Maher ER, Mulligan L, Ponder BAJ, Egelhardt D (1996) Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab in press
18. Shaffer AL, Falk Wade JA, Tortorelli V, Cigan A, Carter C, Hassan K, Hurley CK (1992) HLA-DRw52-associated DRB1 alleles: identification using polymerase chain reaction-amplified DNA, sequence-specific oligonucleotide probes, and a chemiluminescent detection system. Tissue Antigens 39:84-90
19. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma. Cancer Res 54:2852-2855
20. Tory K, Brauch H, Linehan M, Barba D, Oldfield E, Filling-Katz M, Seizinger B, Nakamura Y, White R, Marshall FF, Lerman MI, Zbar B (11989) Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst 81: 1097-1101
21. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HPH, Laidlaw J, Li FP, Klein-Szanto AJP, Seizinger B, Kley N (1994) Germline mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092-1102